James B. Weissman

Chief Business Officer, Dicerna Pharmaceuticals (United States).

Companies

Telesis Bio Inc.Board member Jul 25, 2024 to Jul 26, 2024¹
Dicerna Pharmaceuticals (United States)Chief operating officer Oct 18, 2019 to Dec 29, 2021²
Dicerna Pharmaceuticals (United States)Chief Business Officer Jan 29, 2014 to Aug 23, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Dicerna Pharmaceuticals (United States)0 shares⁴Dec 28, 2021
Telesis Bio Inc.8,390 shares⁵Jul 24, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 24, 2024Granted 8,390 shares of Telesis Bio Inc.⁵
Dec 28, 2021U 18,100 shares at $38.25 of Dicerna Pharmaceuticals (United States)⁴
Dec 15, 2021Shares withheld for tax 1,675 shares at $38.05 of Dicerna Pharmaceuticals (United States)⁶
Dec 15, 2021Exercised options 3,775 shares of Dicerna Pharmaceuticals (United States)⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTelesis Bio Inc., Board member
2
SEC EDGARDicerna Pharmaceuticals (United States), Chief operating officer
3
SEC EDGARDicerna Pharmaceuticals (United States), Chief Business Officer
4
SEC EDGARDicerna Pharmaceuticals (United States) shares after the filing of Dec 28, 2021
5
SEC EDGARTelesis Bio Inc. shares after the filing of Jul 24, 2024
6
SEC EDGARForm 4 filed Dec 17, 2021